Rajasthan
Remdesivir allocation for Rajasthan hiked to 73,600 vials up to May 2 | Jaipur News
JAIPUR: With the Government of India importing 4.50 lakh vials of Remdesivir from other countries, the revised allocation plan of the drug for Rajasthan, up to May 2, has been increased to 73,600 vials, stated a central government document. The revised allocation of Tocilizumab for Rajasthan is 440.
It stated that 20,000 vials of Remdesivir will be supplied by Zydus Cadila; 4,000 vials by Hetero; 27,000 vials by Mylan; 10,000 vials by Cipla; 1,600 vials by Syngene/Sun; 8,000 vials by Jubilant and 3,000 vials by Dr Reddy’s.
Union minister for chemicals and fertilizers Sadanand Gowda on Friday tweeted, “After in-depth review of enhanced availability of Remdesivir due to ramped up production, its allocation plan to all states has been revised. Its increased supply will help in fighting the pandemic with deeper resolve.”
He also attached the revised supply plan of Remdesivir for all states which is valid up to May 2.
“After reviewing the state-wise allotment of Tocilizumab with @Pharmadept, a substantial increase has been made in allotment to all states to ensure adequate availability,” he further tweeted.
A statement issued by the ministry of chemicals and fertilizers on Friday stated, “The Government of India has started importing the vital drug Remdesivir from other countries to ease out the shortage of Remdesivir in the country. The first consignment of 75,000 vials will reach India on April 30.”
“The government has ramped up the production capacity of Remdesivir in the country. As on April 27, the production capacity of the seven licenced domestic manufacturers increased from 38 lakh vials per month to 1.03 crore vials per month. Total 13.73 lakh vials have been supplied across the country by the drug companies in the last seven days (April 21-28 April). The daily supply has gone up from 67,900 vials on April 11 to 2.09 lakh vials on April 28,” the statement added.
It stated that 20,000 vials of Remdesivir will be supplied by Zydus Cadila; 4,000 vials by Hetero; 27,000 vials by Mylan; 10,000 vials by Cipla; 1,600 vials by Syngene/Sun; 8,000 vials by Jubilant and 3,000 vials by Dr Reddy’s.
Union minister for chemicals and fertilizers Sadanand Gowda on Friday tweeted, “After in-depth review of enhanced availability of Remdesivir due to ramped up production, its allocation plan to all states has been revised. Its increased supply will help in fighting the pandemic with deeper resolve.”
He also attached the revised supply plan of Remdesivir for all states which is valid up to May 2.
“After reviewing the state-wise allotment of Tocilizumab with @Pharmadept, a substantial increase has been made in allotment to all states to ensure adequate availability,” he further tweeted.
A statement issued by the ministry of chemicals and fertilizers on Friday stated, “The Government of India has started importing the vital drug Remdesivir from other countries to ease out the shortage of Remdesivir in the country. The first consignment of 75,000 vials will reach India on April 30.”
“The government has ramped up the production capacity of Remdesivir in the country. As on April 27, the production capacity of the seven licenced domestic manufacturers increased from 38 lakh vials per month to 1.03 crore vials per month. Total 13.73 lakh vials have been supplied across the country by the drug companies in the last seven days (April 21-28 April). The daily supply has gone up from 67,900 vials on April 11 to 2.09 lakh vials on April 28,” the statement added.
